Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Eupraxia Pharmaceuticals ...

    NASDAQ: EPRX · Real-Time Price · USD
    5.40
    0.78 (16.88%)
    At close: Jun 27, 2025, 3:59 PM
    5.97
    10.56%
    After-hours: Jun 27, 2025, 05:55 PM EDT

    Eupraxia Pharmaceuticals Statistics

    Share Statistics

    Eupraxia Pharmaceuticals has 35.85M shares outstanding. The number of shares has increased by 0.64% in one year.

    Shares Outstanding

    n/a
    		 35.85M

    Shares Change (YoY)

    n/a
    		 0.64%

    Shares Change (QoQ)

    n/a
    		 0.64%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 27.73M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,437

    FTD / Avg. Volume

    n/a
    		 11.02%

    Short Selling Information

    The latest short interest is 172.2K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 172.2K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 10.45

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 -5.23

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.6

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Eupraxia Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 11.1, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 11.1

    Quick Ratio

    n/a
    		 11.1

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,133,082.06

    Employee Count

    n/a
    		 33

    Asset Turnover

    n/a
    		 n/a

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 48.26K

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 80.86% in the last 52 weeks. The beta is 1.43, so Eupraxia Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.43

    52-Week Price Change

    n/a
    		 80.86%

    50-Day Moving Average

    n/a
    		 3.92

    200-Day Moving Average

    n/a
    		 3.33

    Relative Strength Index (RSI)

    n/a
    		 74.09

    Average Volume (20 Days)

    n/a
    		 13,038

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -209.91K

    Operating Income

    n/a
    		 -37.2M

    Net Income

    n/a
    		 -37.39M

    EBITDA

    n/a
    		 -36.75M

    EBIT

    n/a
    		 -36.9M

    Earnings Per Share (EPS)

    n/a
    		 -1.58
    Full Income Statement

    Balance Sheet

    The company has 33.1M in cash and 71.86K in debt, giving a net cash position of 33.03M.

    Cash & Cash Equivalents

    n/a
    		 33.1M

    Total Debt

    n/a
    		 71.86K

    Net Cash

    n/a
    		 33.03M

    Retained Earnings

    n/a
    		 -131M

    Total Assets

    n/a
    		 29.23M

    Working Capital

    n/a
    		 26.41M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -29.99M and capital expenditures -104.23K, giving a free cash flow of -30.1M.

    Operating Cash Flow

    n/a
    		 -29.99M

    Capital Expenditures

    n/a
    		 -104.23K

    Free Cash Flow

    n/a
    		 -30.1M

    FCF Per Share

    n/a
    		 0
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    EPRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for EPRX is $10.5, which is 126.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10.5

    Price Target Difference

    n/a
    		 126.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 29.38

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist